The combination of ipamorelin with CJC-1295 (a modified GHRH analogue) has attracted considerable research attention due to the complementary nature of their mechanisms
The FDA has begun stepping up some enforcement
In a study of 51 patients with PGBH, all wore a continuous glucose monitor, were instructed to follow their normal diet for 5 days, and then underwent a mixed meal tolerance test on day 6
In this trial, a subgroup of patients was assessed for organ-specific insulin sensitivity, hepatic lipid handling, and adipose dysfunction: the results showed that liraglutide improved hepatic and adipose insulin sensitivity and reduced the hepatic de novo lipogenesis [77], a key component of the hepatic fat accumulation in NASH
Patients have reported debilitating conditions such as gastroparesis (stomach paralysis), acute pancreatitis, gallbladder disease requiring surgery, and even intestinal blockages